Back

Enhanced bedside PCI risk score predicting major adverse cardiovascular events

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Risk scores at coronary revascularisation Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Luokai Wang

National Heart Centre Singapore, Singapore (Singapore)

9 More presentations in this session

Presentation thumbnail
Syntax-Score II Based Assessment for role of complete revascularization by using percutaneous coronary intervention among Patients with Chronic Total Occlusion
Doctor M. Shiba (Tokyo, JP)
Abstract
Presentation thumbnail
Validation of an NCDR-score-based risk model for cardiac catheterization procedures in a european population
Doctor M. Brockmeyer (Duesseldorf, DE)
Abstract Slides
Presentation thumbnail
The ARDVAARC study: real-world outcomes and the utility of bleeding risk scores in patients who require anticoagulation following percutaneous coronary intervention (PCI)
Doctor M. Li Kam Wa (London, GB)
Abstract Slides
Presentation thumbnail
Utility of SYNTAX score II in revascularization decision-making process in patients with acute coronary syndrome without local heart surgery facilities
Doctor F. Abcha (Tunis, TN)
Abstract Slides
Presentation thumbnail
Comparison of residual added index with residual sYNTAX score in the risk stratification of patients with incomplete coronary percutaneous revascularization after ST-elevation myocardial infarction
Associate Professor L. Di Serafino (Naples, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 7 - Risk scores at coronary revascularisation

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Percutaneous intervention is better than surgery in real life for most patients: pro
thumbnail
Congress Presentation
Association of PCI with outcomes in stable coronary artery disease
thumbnail
Congress Presentation
Prognostic impact of intravascular imaging in percutaneous coronary intervention according to atherothrombotic risk

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources